VICI Properties Q1 2026 Earnings EPS Surpasses Estimates by 1443 Stock Edges Higher Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported AEE Q1 2026 Earnings EPS Beats Estimates as Operational Strength Drives Performance HYPR Q1 2026 Earnings EPS Beat Highlights Cost Discipline Amid Disclosed Revenue Gap Envoy Medical Inc COCH Q1 2026 Earnings Strong EPS Beat Amidst PreRevenue Stage